Direct-Acting Oral Anticoagulants as Prophylaxis Against Thromboembolism in the Nephrotic Syndrome

Direct-Acting Oral Anticoagulants as Prophylaxis Against Thromboembolism in the Nephrotic Syndrome

We report 2 cases of apixaban use as prophylaxis against thromboembolism in the nephrotic syndrome (NS), and review the existing literature on direct-acting oral anticoagulant (DOAC) use in this scenario. Our cases appear to be the first reported use of apixaban as prophylaxis against thromboembolis...

Full description

Bibliographic Details
Main Authors: Donal J. Sexton, Declan G. de Freitas, Mark A. Little, Tomas McHugh, Colm Magee, Peter J. Conlon, Conall M. O’Seaghdha
Format: Article
Language:English
Published: Elsevier 2018-07-01
Series:Kidney International Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S246802491830041X

Similar Items

Similar Items